Brief: Anders Vadsholt Takes Over As CEO Of Orphazyme
Feb 28 (Reuters) - Orphazyme A/S ORPHA.CO :
* REG-ANDERS VADSHOLT TAKES OVER AS CEO OF ORPHAZYME
* TODAY ANNOUNCES THAT CFO ANDERS VADSHOLT WILL BE APPOINTED
CEO
OF ORPHAZYME EFFECTIVE AS OF MARCH 1, 2022 AND THEREBY REPLACING
CHRISTOPHE BOURDON AS ANNOUNCED IN COMPANY ANNOUNCEMENT NO.
3/2022 OF JANUARY 31, 2022
Source text for Eikon: ID:nGNEbSpjLH
Further company coverage: ORPHA.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Strategic Partners A/S
See all newsBrief: Strategic Partners Reports H1 EBIT Loss Of DKK 1.0 Mln, Maintains FY Guidance
Brief: Strategic Partners Buys Three Retail Properties In Tilst
Brief: Strategic Partners Q1 EBIT Loss At DKK 0.6 Mln
Brief: Strategic Partners Buys DKK 3 Mln Of Shares In Gyldendal
Brief: Strategic Partners 9-month EBIT Loss DKK 1.7 Mln